Teens with heart disease try home video workouts to boost fitness

NCT ID NCT06015191

Recruiting now Symptom relief Sponsor: Children's Mercy Hospital Kansas City Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether live, group exercise sessions delivered via video chat can improve fitness in teens (ages 12-19) with certain types of congenital heart disease. 74 participants will either join the remote exercise program or receive standard exercise handouts. The main goal is to see if the remote program improves peak oxygen use during exercise (a key fitness measure) over 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Remote cardiac rehabilitation (live video exercise sessions)
What this could lead to: If successful, this could provide a convenient, effective way for teens with heart disease to improve their fitness and heart health from home.
What could go wrong: This is a small, early-stage trial (74 people) testing feasibility and short-term effects. The exercise program may not improve fitness more than standard advice, and long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL HEART DISEASE IN CHILDREN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congenital heart disease dextro-looped transposition of the great arteries Motor Activity tetralogy of fallot univentricular heart

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONGENITAL HEART DISEASE IN CHILDREN

Contacts and locations

Locations

Children's Mercy Kansas City
RECRUITING

Kansas City, Missouri, 64108, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.